NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Yes. I agree. Could be funded trial for Direct or positive results anticipated for L. Many CI combo trials do not get funding from the BP source... but some do. Leans toward positive L results. Further, not all indications for Direct-2 will have the CI option, so that too reduces chances of that trial being funded... making the alter explanation more likely.

They have all details about individual patient age and health, etc. They have the ability to model the expected mOS and mPFS for the blended group using that information. So even with the enrollment details now in our hands, they know better just how special these results (probably) are... or not. So such foreshadowing as you reference does have meaning.